Medicare Enrolled

Dr. Gregg Faiman, MD

Internal Medicine · Mayfield Hts, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5850 LANDERBROOK DR STE 100, Mayfield Hts, OH 44124
4406462200
In practice since 2006 (19 years)
NPI: 1508959644 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faiman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faiman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Faiman

Dr. Gregg Faiman is an internal medicine specialist in Mayfield Hts, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Faiman performed 848 Medicare services across 423 unique beneficiaries.

Between the years covered by Open Payments, Dr. Faiman received a total of $297,087 from 79 pharmaceutical and/or device companies across 1324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Faiman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 31% volume in OH $297,087 industry payments

Medicare Practice Summary

Medicare Utilization ↗
848
Medicare services
Top 31% in OH for internal medicine
423
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~45 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
563 $86 $175
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
242 $9 $40
New patient office visit, complex (60-74 min) 43 $141 $340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$297,087
Total received (2018-2024)
Avg $42,441/year across 7 years
Top 0% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
79
Companies
1,324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$284,925 (95.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,162 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18,093
2023
$7,847
2022
$43,061
2021
$37,112
2020
$28,006
2019
$66,201
2018
$96,767

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$16,491
Lilly USA, LLC
$290
Abbott Laboratories
$187
ABBVIE INC.
$141
Novartis Pharmaceuticals Corporation
$121
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Corcept Therapeutics
$79
PFIZER INC.
$71
Amgen Inc.
$69
Merck Sharp & Dohme LLC
$68
VIVUS LLC
$59
Astellas Pharma US Inc
$38
Dexcom, Inc.
$36
AIMMUNE THERAPEUTICS, INC.
$35
Medtronic, Inc.
$32
Neurocrine Biosciences, Inc.
$31
Kyowa Kirin, Inc.
$28
BETA BIONICS, INC.
$27
Averitas Pharma Inc.
$24
Antares Pharma, Inc.
$24
Xeris Pharmaceuticals, Inc.
$22
Verity Pharmaceuticals Inc.
$20
GlaxoSmithKline, LLC.
$20
Mannkind Corporation
$19
Chiesi USA, Inc.
$19
Ascendis Pharma Inc
$18
Phathom Pharmaceuticals, Inc.
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
Top 3 companies account for 93.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$269,822
Merck Sharp & Dohme Corporation
$14,311
AstraZeneca Pharmaceuticals LP
$1,352
Lilly USA, LLC
$1,224
Abbott Laboratories
$1,116
Amgen Inc.
$1,101
Boehringer Ingelheim Pharmaceuticals, Inc.
$953
SANOFI-AVENTIS U.S. LLC
$421
Shire North American Group Inc
$409
ABBVIE INC.
$341
Takeda Pharmaceuticals U.S.A., Inc.
$327
Currax Pharmaceuticals LLC
$299
Janssen Pharmaceuticals, Inc
$298
PFIZER INC.
$291
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$277
GENZYME CORPORATION
$257
VIVUS, Inc.
$246
Dexcom, Inc.
$210
AbbVie, Inc.
$207
Corcept Therapeutics
$201
Insulet Corporation
$182
Mannkind Corporation
$180
Xeris Pharmaceuticals, Inc.
$165
IBSA Pharma Inc.
$158
Merck Sharp & Dohme LLC
$140
Antares Pharma, Inc.
$134
Novartis Pharmaceuticals Corporation
$134
Amarin Pharma Inc.
$130
VIVUS LLC
$127
AbbVie Inc.
$123
Biohaven Pharmaceutical Holding Company Ltd.
$116
MannKind Corporation
$112
Radius Health, Inc.
$112
Bayer HealthCare Pharmaceuticals Inc.
$104
Amneal Pharmaceuticals LLC
$90
Astellas Pharma US Inc
$82
GlaxoSmithKline, LLC.
$78
Medtronic, Inc.
$70
Bayer Healthcare Pharmaceuticals Inc.
$67
LifeScan, Inc.
$56
Alexion Pharmaceuticals, Inc.
$53
Horizon Therapeutics plc
$52
Tandem Diabetes Care, Inc.
$48
Averitas Pharma Inc.
$46
Clarus Therapeutics Inc.
$45
Genentech USA, Inc.
$43
Ultragenyx Pharmaceutical Inc.
$43
Aytu BioScience, Inc
$41
Acerus Pharmaceuticals Corporation
$40
Amryt Pharma Holdings Ltd
$40
EISAI INC.
$39
Dynavax Technologies Corporation
$37
Gemini Laboratories, LLC
$36
AIMMUNE THERAPEUTICS, INC.
$35
Neurocrine Biosciences, Inc.
$31
Orexigen Therapeutics, Inc.
$30
Phadia US Inc.
$28
Kyowa Kirin, Inc.
$28
BETA BIONICS, INC.
$27
Ironwood Pharmaceuticals, Inc
$24
Nalpropion Pharmaceuticals LLC
$24
Supernus Pharmaceuticals, Inc.
$21
Verity Pharmaceuticals Inc.
$20
Chiesi USA, Inc.
$19
Ascendis Pharma Inc
$18
ARBOR PHARMACEUTICALS, INC.
$17
Medtronic Vascular, Inc.
$17
Eisai Inc.
$16
Synergy Pharmaceuticals Inc
$16
Phathom Pharmaceuticals, Inc.
$15
Biohaven Pharmaceuticals, Inc.
$15
Exact Sciences Corporation
$14
NESTLE HEALTHCARE NUTRITION INC.
$14
SANOFI PASTEUR INC.
$12
Sanofi Pasteur Inc.
$12
Nabriva Therapeutics, plc
$12
Valeritas, Inc.
$12
Kowa Pharmaceuticals America, Inc.
$11
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 96.1% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AREXVY · Aimovig · Androgel · BAQSIMI · BASAGLAR · BREZTRI · BYDUREON · Belviq · CHANTIX · CONTRAVE · CREON · CYCLOSET · ClosureFast · Cologuard Collection Kit · Creon · Crysvita · DUZALLO · Dexcom CGM · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL · GARDASIL 9 · GATTEX · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Heplisav-B · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · Lenvima · Licart · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Macrilen · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NURTEC ODT · Natesto · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · Otezla · Otrexup · Ozempic · PAXLOVID · PNEUMOVAX 23 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QSYMIA · QUTENZA · REBINYN · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tirosint · Tlando · Tresiba · Trulance · Tymlos · UBRELVY · UNITHROID · V-GO · VARIVAX · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xenleta · Xofluza · Xultophy 100/3.6 · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in OH.

Looking for an internal medicine specialist in Mayfield Hts?
Compare internal medicine physicians in the Mayfield Hts area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,185
Per 100K population
94.8
County median income
$62,823
Nearest hospital
HILLCREST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Faiman is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of OH peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Faiman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Faiman performed 563 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faiman receive payments from pharmaceutical companies?
Yes. Dr. Faiman received a total of $297,087 from 79 companies across 1,324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faiman's costs compare to other internal medicine physicians in Mayfield Hts?
Dr. Faiman's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faiman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →